European Biosafety Association
1972, PhD, University of Manchester; 1994, postgraduate diploma in Health and Safety, Aston University. Nearly 20 years in academia, working in biochemistry and molecular biology in the UK, the Middle East and Germany; 1993-96, Health and Safety Executive, HM Inspectors of Health and Safety; 1996, Specialist, Genetic Modification Section, Biological Agents Corporate Topic Group, responsible for ensuring compliance with legislation governing both contained use and deliberate release activities, inspecting locations where these activities were carried out; also involved in providing advice and in drafting formal guidance on this topic. Until retirement at end of 2012, Global Biosafety Manager, AstraZeneca. Currently independent consultant. Member, Scientific Advisory Committee on Genetic Modification (Contained Use). Former Member, UK Advisory Committee on Genetic Modification, and its associated Technical Sub-Committee.